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Abstract Localized surface plasmon resonance (LSPR) spec-
troscopy and imaging are emerging biosensor technologies
which tout label-free biomolecule detection at the nanoscale
and ease of integration with standard microscopy setups. The
applicability of these techniques can be limited by the restric-
tions that surface-conjugated ligands must be both sufficiently
small and orientated to meet analyte sensitivity requirements.
We demonstrate that orientated single domain antibodies
(sdAb) can optimize nanoplasmonic sensitivity by comparing
three anti-ricin sdAb constructs to biotin-neutravidin, a model
system for small and highly orientated ligand studies. LSPR
imaging of electrostatically orientated sdAb exhibited a ricin
sensitivity equivalent to that of the biotinylated LSPR biosen-
sors for neutravidin. These results, combined with the facts
that sdAb are highly stable and readily produced in bacteria
and yeast, build a compelling case for the increased utilization
of sdAbs in nanoplasmonic applications.
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Introduction
Localized surface plasmon resonance (LSPR) biosensing is a
label-free technique that enables biomolecule detection with
nanoscale spatial resolution. Since its introduction, the tech-
nique has found a broad range of applications including stud-
ies of DNA-protein interactions [1], toxins [2], proteins [3, 4],
and vesicles [5]. The small size of the individual sensors,
typically 40 to 150 nm in diameter, has the potential to enable
sensor miniaturization to a scale unapproachable by the
closely related planar technique of surface plasmon resonance
(SPR) biosensing. Also unique to LSPR is that the
nanoplasmonic resonance condition is satisfied in a simple
reflected or transmitted light geometry, common to both mi-
croscopy and spectroscopy applications, whereas SPR excita-
tion requires incident light that is totally internally reflected.
As a result, LSPR spectroscopy and imaging (LSPRi) are
increasingly being integrated into live-cell microscopy exper-
iments for the detection of secreted proteins while simulta-
neously imaging the cells with more traditional techniques
such as fluorescence and bright field [6–9].
Continued progress in the field of nanoplasmonic biosens-
ing is highly dependent upon meeting two design challenges
related to surface functionalization. First, the reduced sensor
area limits the number of conjugated ligands, making orienta-
tion critical for maximizing the probability of analyte capture.
The most common ligands in biosensing are full antibodies,
surface conjugated via their lysine residues or N-terminal ami-
no groups. The typical antibody will have 60–80 of such res-
idues resulting in a range of surface orientations, many of
which are not optimal for analyte detection [10]. Second, ex-
perimental evidence and theoretical models show the nano-
structures can exhibit a wide range of electromagnetic field
decay lengths into the solution with some as short as 5 to
15 nm [11, 12]. Such nanoscale distances are largely filled
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when using intact IgG antibodies that have typical dimensions
of 14.5 nm×8.5 nm×4.0 nm [13]. As a result, LSPR optimi-
zation requires at a minimum highly oriented full antibodies as
ligands [14] and preferably lower molecular weight molecules
which can be modified to enhance preferential orientation.
There are a number of classes of biomolecules which have
been engineered with the goal of meeting these criteria includ-
ing single chain antibodies (ScFvs), Fab fragments, and
aptamers. Orientated ScFvs, which are roughly one fifth the
size of full antibodies, were recently shown to enhance LSPR
sensitivity relative to whole antibody counterparts [15]. In
general, however, attempts to orient ScFvs and Fab fragments
for improved biosensor sensitivity have produced decidedly
mixed results [16–22, 10]. In addition, ScFvs and Fab frag-
ments with molecular weights of approximately 27 and
50 kDa, respectively, are still relatively large ligands for many
LSPR biosensing applications, leaving room for improved
sensitivity if the size can be further reduced.
Single domain antibodies (sdAb), also called nanobodies,
are the recombinant variable domain derived from heavy
chain-only antibodies found in camelids, i.e., camels, llamas,
and alpacas. Consisting of only a single domain endows sdAb
with a number of attractive properties for biosensor applica-
tions. First, their small size (∼15 kDa or ∼1/10 the size of a
full IgG) allows for facile production in yeast or bacteria,
alone or as fusions with effector proteins. Second, both their
small size and being a single domain provides them with re-
markable thermostability, being able to refold and recover
their binding ability following heat or chemical denaturation.
Finally, sdAb are derived from true antibodies; thus, they pos-
sess the high affinity and specificity for which antibodies are
renowned. SdAb, which recognize a plethora of targets, have
been developed, and orientated sdAb have recently been dem-
onstrated to improve SPR biosensor sensitivity [23, 24]. Our
primary focus has been on the development of robust reagents
for the detection of bio-threat agents [25, 26]. Of those re-
agents, the sdAb which bind ricin have been the most studied,
and thus make well defined tools for testing the utility of sdAb
in novel sensor applications [27, 28].
Here, we compare the sensitivity of LSPRi for orientated
versus randomly surface-conjugated sdAb. Using anti-ricin
sdAb, we first demonstrate the ability to modify the carboxyl
terminus with positively charged peptide tails and rhizavidin
fusion proteins for preferential surface orientation. The posi-
tively charged tail was designed to aid in surface orientation
by means of an electrostatic interaction with a negatively
charged surface. The rhizavidin fusion construct was designed
to assist in orientation by binding to a biotinylated surface,
preferentially directing the sdAb into the solution. Using
SPR imaging (SPRi), we show that these modified sdAb have
enhanced surface conjugation efficiencies and improved sen-
sitivity to ricin relative to the non-orientated sdAb. We then
measured the sdAb sensitivity to ricin on an LSPRi platform
and compared the results to the biotin-neutravidin binding
pair, a commonly used standard for biosensing applications
and an apt comparison since biotin is readily orientated and
ricin and neutravidin have similar molecular weights [3, 29].
Despite the fact that the sdAb ligands were 62-fold greater in
mass than biotin, the measured sensitivities were statistically
equivalent. We conclude that the relatively small size and the
ability to readily modify sdAb for orientated surface conjuga-
tion make them optimal ligand candidates for LSPR imaging
and spectroscopy applications. The current sensitivity study
lays the groundwork for future work in determining the LSPRi
limit of detection of each construct and multiplexed toxin-
sensing applications.
Experimental
The sequence and binding characteristics of the ricin-binding
sdAb C8 and D12 have been previously described [27, 28];
both have sub-nM affinity for the toxin ricin. The clone D12f
is a version of D12 in which an unpaired cysteine was mutated
to a serine causing no change in sdAb affinity. The C8 sdAb,
lacking the upper hinge region, was cloned into pET22b for
protein expression. Protein was purified using immobilized
metal affinity chromatography followed by size exclusion
chromatography on an FPLC as previously described [26,
30]. Protein sequences of all sdAb constructs are detailed in
the Supplementary Material.
The construct referred to herein as C8-zip is a genetic fu-
sion of the C8 sdAb with a positively charged leucine zipper
described by Oshea et al. [31]. DNA including a glycine-
serine linker followed by the zipper sequences was synthe-
sized by GenScript (Piscataway, NJ) and included flanking
Not I and Xho I restriction endonuclease sites. We cloned
the linker-zipper sequence into pET22b and then mobilized
the C8 sdAb into the modified pET22b through the Nco I and
Not I sites; DNA sequencing was used to confirm the con-
structs. Protein was produced from the periplasmic space in a
protocol identical to that used to purify C8. This C8-Zip con-
struct had initially been prepared to facilitate sdAb heterodi-
mer formation [32].
The D12f-rhiz construct is a genetic fusion of the D12f
sdAb with the biotin binding protein rhizavidin (rhiz).
Unlike our previously described sdAb-rhiz fusion construct,
the D12f-rhiz does not include the upper hinge sequence be-
tween the D12f and rhiz. Protein production was as described
for our previous sdAb-rhiz fusions [33].
Details of the LSPR chip fabrication and the LSPRi mea-
surement setup have been published previously [34, 29]. In
short, square arrays of gold nanostructures were patterned on
No. 1.5 glass coverslips using electron-beam nanolithography
(Raith GmbH) to expose a bilayer resist structure consisting of
polymethyl methacrylate and ethyl lactate methyl
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methacrylate copolymer purchased from Microchem Corp.
Each array measured 6μm×6μm and consisted of 400 evenly
spaced nanostructures separated by a pitch of 300 nm. The
bases of the nanostructures were circular in cross section with
diameters of 70±5 nm and the heights were 75±2 nm, giving
a plasmonic resonance peak centered at ∼635 nm in 10 mM
phosphate buffered saline (Thermo Scientific). Protein bind-
ing to the Au surface creates a perturbation in the local index
of refraction which induces a redshift in the resonance peak as
well as enhanced scattering. In the LSPRi measurement, this
response is manifested as an increase in the nanoplasmonic
array’s brightness as imaged by the camera. We have shown,
using analytes such as neutravidin and IgG proteins, that this
response can be calibrated to the fractional occupancy of
surface-bound receptors. Commercial SPRi has sensors
that are orders of magnitude larger in surface area but
operates on a similar physical principle. When using the
same functionalization chemistries, results from the two
techniques can be correlated [8, 34].
The chip was loaded onto a custom-built microfluidic as-
sembly consisting of a 300-μL chamber to which the analyte
solution was introduced using a peristaltic pump from Instech
Laboratories (P720). All imagery was acquired using Zeiss
Zen software, an inverted Zeiss Axio Observer microscope,
a 40X/1.4 NA objective, and a thermoelectrically cooled 16-
bit sCMOS camera from Hamamatsu (Flash 4.0) operated in
2×2 binning mode. Images were collected in a reflected light
geometry using Koehler illumination, a 100 W halogen lamp,
and crossed polarizers to reduce the collection of light
scattered from the substrate. Error bars in the LSPRi response
represent the standard deviation from nine averaged arrays.
Unless otherwise shown, the error bars are within the size of
the data markers.
SPRi measurements were conducted with Bio-Rad’s
XPR36 protein analysis system, the sensors of which
consisted of a gold thin film deposited atop a glass prism for
excitation of surface plasmon polaritons by total internal re-
flection. Once inserted into the instrument, each chip is
microfluidically arrayed into 36 measurement spots. This en-
abled a range of sdAb ligands to be functionalized on a single
chip in contrast to the LSPRi setup in which each experiment
consisted of only one ligand type. All LSPRi and SPRi mea-
surements were conducted at 25 °C. Error bars in the SPR
response are the standard deviation from averaging five mea-
surement spots on the same chip. Unless otherwise shown, the
error bars are within the size of the data markers.
For SPRi studies of sdAb, the Bio-Rad chips were cleaned
down to the bare gold surface by RF plasma ashing at 40W in
300 mTorr of a 5 % hydrogen, 95 % argon mixture, and then
functionalized with a two-component self-assembled mono-
layer (SAM) by immersion for 18 h in an ethanolic-based thiol
solution (0.5 mM), consisting of a 3:1 ratio of SH-(CH2)8-
EG3-OH (SPO) to SH-(CH2)11-EG3-COOH (SPC)
(Prochimia Surfaces Sp.) for C8 and C8-zip studies.
The chips were then rinsed with EtOH and dried under
flowing nitrogen gas. Activation of the SPC component
consisted of introducing a 33 mM: 133 mM ratio of N-
hydroxysulfosuccinimide (sulfo-NHS) and 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC)
from Thermo Scientific in ultrapure water (DDW; EMD
Millipore) for 5 min at a flow rate of 30 μL/min. This was
followed by a 5-min rinse with DDW and the introduction of
the sdAb under the range of concentration and pH conditions
described in the BResults and Discussion^ section. For the
D12f-rhiz studies, a 2-mg/mL solution of (+)-biotinyl-3,6-
dioxaoctanediamine (amine-PEG2-biotin) from Thermo
Scientific was introduced over the activated surface at
30 μL/min for 5 min followed by a range of D12f-rhiz con-
centrations as described in the BResults and Discussion^ and
Supplementary Material sections. Finally, in all cases,
unreacted –COOH groups were blocked by flowing 0.1 M
ethanolamine (Bio-Rad) in PBS for 5 min at 30 μL/min. For
the LSPR chips, this process was repeated except all solutions
were manually drop coated and washed while inside the
custom-built microfluidic assembly.
The identical surface cleaning and SAM layer formation
protocol was applied for LSPRi biotin-neutravidin studies ex-
cept that the two-component SAM layer consisted of a 3:1
ratio of SH-(CH2)8-EG3-OH (SPO) to SH-(CH2)11-EG3-NH2
(SPN) (Prochimia Surfaces Sp.). LSPR chips were drop coat-
ed with 100 μL of 2 mg/mL sulfo-NHS-biotin (Thermo
Scientific) in PBS, incubated for 30 min at room temperature,
rinsed with DDW, and dried in flowing nitrogen.
Results and Discussion
Three ligands were used in this study: an unmodified sdAb
(C8), a genetic fusion of C8 with a positively charged peptide
(C8-zip), and a genetic fusion of the D12f sdAbwith the biotin
binding protein rhizavidin (D12f-rhiz). Both the C8 and D12f
sdAb that compose the ligand provide the recognition function
of the constructs and are specific for ricin. They bind the same
epitope on the toxin and exhibit nearly identically sub-nM
affinities for their cognate antigen. Structurally, the binding
loops of sdAb are located on the opposite side from their
C-terminus, enabling the construction of fusions to fa-
cilitate directional immobilization. We hypothesized that
the positively charged lysines on the C-terminus of C8-
zip protein would maximize the potential for directional
immobilization on the negatively charged –COOH sur-
face, resulting in an orientation with the tail coupled to
the surface and the binding region oriented into solution
for optimal antigen capture. In a similar way, the D12f-rhiz
enables directional immobilization but via the biotinylated
surface [33].
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To optimize the plasmonic sensitivity to ricin, a range of
ligand concentrations were introduced over the EDC/Sulfo-
NHS activated SPR surface followed by a saturating concen-
tration of ricin (100 nM). Fig. 1a shows the SPR response to
C8-zip in which the concentration was varied from 0.4 to
30 μg/mL in PBS, pH 7.0. At the higher ligand concentra-
tions, there were diminishing returns with regards to ricin-
binding capacity (Fig. 1b) with the 30 μg/mL exposed surface
binding only 8 % more than the surface coated at 10 μg/mL.
Exceeding this 30 μg/mL value resulted in a rapid in-
crease in non-specific binding and minimal ricin sensi-
tivity enhancement. C8 and D12f-rhiz exhibited similar
surface saturation concentrations, lying between 1 and
30 μg/mL (Supplementary Material). Ligand concentration
values such as the 30 μg/mL value for C8-zip were defined
as optimal based on these criteria of maximizing sensitivity
and minimizing non-specific binding. A control study was
also conducted in which a 100-nM ricin solution was first
incubated with 5 μM of C8 for 45 min to block the ricin-
binding sites. When the blocked ricin was introduced over a
C8-functionalized surface, no response was detectable, dem-
onstrating levels of non-specific binding below the SPRi limit
of detection (Fig. 1b).
A study was then conducted of SPR sensitivity to ricin at
each ligand’s optimal concentration. The 36-array
microfluidic architecture of the XPR36 allowed for these mea-
surements to be taken simultaneously alongside control lanes,
thus eliminating uncertainties from chip-to-chip variations.
C8-zip exhibited the highest response to 100 nM ricin,
320 % higher than that of C8 and 42 % higher than that of
D12f-rhiz (Fig. 2a). In order to help isolate sensitivity im-
provements due to ligand orientation, we next introduced ricin
over C8 and C8-zip surfaces prepared with similar ligand
responses (1300±120 RU) which is indicative of equivalent
ligand surface densities. Figure 2b shows the SPR response to
100 nM ricin for these surface conjugations. The C8-zip sur-
face again exhibited the highest response to 100 nM ricin,
140 % higher than that of C8.
Fig. 1 a SPR response to the conjugation of C8-zip sdAbs for a range of
ligand concentrations followed by the introduction of 100 nM ricin in (b).
The control study in b consisted of a 100-nM ricin solution incubated
with 5 μM of C8 for 45 min to block the binding sites. It was then
introduced over a 4.0-μg/mL C8 functionalized surface. The vertical
dashed line separates the association phase (left) in which the ligand or
analyte solution is flowing over the surface from the dissociation phase
(right) in which buffer flows over the surface
Fig. 2 a SPR response to 100 nM ricin of optimally prepared C8-zip, C8,
and D12f-rhiz surfaces. b SPR analyte response to 100 nM ricin
following C8-zip and C8 ligand conjugations with responses of 1300±
120 RU. Measurements were conducted in parallel by multiplexing a
single sensor chip to eliminate chip-to-chip variations. The vertical
dashed line separates the association phase (left) in which the analyte
solution is flowing over the surface from the dissociation phase (right)
in which buffer flows over the surface
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To further investigate relative ligand orientation, we com-
pared the analyte binding activity, A, of the conjugated C8 and
C8-zip ligands, defined as the moles of captured analyte di-
vided by the moles of surface-conjugated ligand. In SPR, the
moles of a given molecule deposited on the surface is propor-
tional to the instrument response, X, divided by the molecular
weight, m, so that the activity is readily expressed as
A ¼ XA⋅mL
XL⋅mA
where XL and XA are the SPR responses in RU to the binding
of ligand and analyte, respectively, mL and mA are the molec-
ular weights of the ligand and analyte, respectively, and it is
assumed that the ligands are monovalent.
To properly isolate the effect of orientation on A, care must
be taken to work in the dilute ligand limit in order to minimize
steric hindrance effects. If analyte molecules can repel one
another at the surface, the result is a reduced activity value
unrelated to ligand orientation. Figure 3 compares the activity
of C8-zip to C8 for a range of surface ligand densities by
exposing the surface to ligand concentrations of 0.25 to
10μg/mL for 300 s. The ligand surface density was calculated
assuming a sensor calibration of 1 RU=1 pg/mm2 [35]. At
higher surface densities, the activity values of the two ligands
converge as expected for a surface dominated by steric hin-
drance. As the surface concentration is reduced, both exhibit
marked increases with maximum C8-zip and C8 activities of
65 and 36 %, respectively. The results indicate that the posi-
tively charged tail of the C8-zip improved surface orientation
and are consistent with the enhanced sensitivity measured in
Fig. 2. We also observed improved sensitivity for the orientat-
ed sdAbwhen using SPRGLC sensor chips, designed by Bio-
Rad for general amine coupling via a compact polymer layer
with a binding capacity of approximately one protein mono-
layer (Supplementary Material).
For the corresponding nanoplasmonic response studies, a
functionalization protocol identical to that used for the SPR
study in Fig. 2a was applied to the gold nanostructures of the
custom-made LSPR chips. Response data to 100 nM ricin
were determined by averaging the mean intensity of nine ar-
rays, each array consisting of 400 nanostructures (Fig. 4a, b).
As with the SPR results, the C8-zip surface was the most
sensitive of the three ligands, with a saturation response that
was 104 % greater than that of C8 and 61 % greater than that
of D12f-rhiz (Fig. 4c).
To further characterize the sensitivity of the C8-zip func-
tionalized surface, we conducted LSPRi studies in which the
surface was functionalized with biotin and exposed to a 100-
nM neutravidin solution, a commonly used standard in
nanosensor characterization. Both of these receptor-ligand
pairs have exceptionally high binding affinities and both ricin
and neutravidin have approximately the same molecular
weight (60 kDa). Biotin, however, is readily orientated and
has a molecular weight of 244 Da, 62 times lower than that
of C8-zip. Thus, the differences in LSPRi sensitivity to analyte
should be reflective of ligand size and degree of orientation.
Fig. 3 Ricin saturation activity versus ligand surface density for C8-zip
and C8. Ligand surface density was calculated assuming a sensor
calibration of 1 RU=1 pg/mm2. The ricin concentration was 100 nM
for all experiments
Fig. 4 a LSPRi of nine arrays, each array consisting of 400
nanostructures. The image is false colored red to indicate the resonance
wavelength of 635 nm. b Scanning electron microscopy of an array of
400 nanostructures. c LSPRi response to 100 nM ricin for C8-zip, C8, and
D12f-rhiz surfaces compared to that of a biotinylated surface for 100 nM
neutravidin
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Interestingly, Fig. 4c shows the responses of the C8-zip
and biotinylated surfaces to their cognate analytes were
statistically equivalent, demonstrating that the small size
and highly oriented conjugation of the C8-zip molecules
are well suited for LSPRi applications. Future work will
build on these results to estimate the limit of detection for
each construct.
Conclusions
When conjugated to plasmonic nanostructures, orientated
sdAb exhibited enhanced LSPRi sensitivity which matched
that of biotinylated surfaces to neutravidin, long considered
a model system for small and orientated ligand studies. The
additional facts that sdAb produce well in bacteria and yeast,
are readily modified, and robust to denaturation make them
well suited for a broad range of SPR and LSPR biosensing
applications. The application of LSPRi to ricin detection is an
important step forward in the design of small, readily deploy-
able biosensors against bio-threat agents.
Acknowledgments We are grateful for generous funding from the
Naval Research Laboratory’s Institute for Nanoscience and 6.1
base funds.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons license, and
indicate if changes were made.
References
1. Endo T, Kerman K, Nagatani N, Takamura Y, Tamiya E (2005)
Label-free detection of peptide nucleic acid-DNA hybridization
using localized surface plasmon resonance based optical biosensor.
Anal Chem 77(21):6976–6984. doi:10.1021/ac0513459
2. Park JH, Byun JY, Mun H, Shim WB, Shin YB, Li T, Kim MG
(2014) A regeneratable, label-free, localized surface plasmon reso-
nance (LSPR) aptasensor for the detection of ochratoxin A. Biosens
Bioelectron 59:321–327. doi:10.1016/j.bios.2014.03.059
3. Haes AJ, Van Duyne RP (2002) A nanoscale optical blosensor:
sensitivity and selectivity of an approach based on the localized
surface plasmon resonance spectroscopy of triangular silver nano-
particles. J Am Chem Soc 124(35):10596–10604. doi:10.1021/
ja020393x
4. Sepulveda B, Angelome PC, Lechuga LM, Liz-Marzan LM (2009)
LSPR-based nanobiosensors. Nano Today 4(3):244–251. doi:
10.1016/j.nantod.2009.04.001
5. Dahlin AB, Jonsson MP, Hook F (2008) Specific self-assembly of
single lipid vesicles in nanoplasmonic apertures in gold. AdvMater
20(8):1436. doi:10.1002/adma.200701697
6. Endo T, Yamamura S, Kerman K, Tamiya E (2008) Label-free cell-
based assay using localized surface plasmon resonance biosensor.
Anal Chim Acta 614(2):182–189. doi:10.1016/j.aca.2008.03.022
7. Oh BR, Huang NT, Chen WQ, Seo JH, Chen PY, Cornell TT,
Shanley TP, Fu JP, Kurabayashi K (2014) Integrated
nanoplasmonic sensing for cellular functional immunoanalysis
using human blood. ACS Nano 8(3):2667–2676. doi:10.1021/
nn406370u
8. Raphael MP, Christodoulides JA, Delehanty JB, Long JP, Byers JM
(2013) Quantitative imaging of protein secretions from single cells in
real time. Biophys J 105(3):602–608. doi:10.1016/j.bpj.2013.06.022
9. Wang S, Ota S, Guo B, Ryu J, Rhodes C, Xiong Y, Kalim S, Zeng
L, Chen Y, Teitell MA, Zhang X (2011) Subcellular resolution
mapping of endogenous cytokine secretion by nano-plasmonic-
resonator sensor array. Nano Lett 11(8):3431–3434. doi:10.1021/
nl2018838
10. Wimalasena RL, Wilson GS (1991) Factors affecting the specific
activity of immobilized antibodies and their biologically-active
fragments. J Chromatogr Biomed Appl 572(1–2):85–102.
doi:10.1016/0378-4347(91)80475-r
11. Haes AJ, Zou SL, Schatz GC, Van Duyne RP (2004) A nanoscale
optical biosensor: the long range distance dependence of the local-
ized surface plasmon resonance of noble metal nanoparticles. J
Phys Chem B 108(1):109–116. doi:10.1021/jp0361327
12. Rindzevicius T, Alaverdyan Y, Kall M, Murray WA, Barnes WL
(2007) Long-range refractive index sensing using plasmonic nano-
structures. J Phys Chem C 111(32):11806–11810. doi:10.1021/
jp072564w
13. Bagci H, Kohen F, Kuscuoglu U, Bayer EA, Wilchek M (1993)
Monoclonal anti-biotin antibodies simulate avidin in the recogni-
tion of biotin. FEBS Lett 322(1):47–50. doi:10.1016/0014-
5793(93)81108-c
14. Soler M, Estevez MC, Alvarez M, Otte MA, Sepulveda B, Lechuga
LM (2014) Direct detection of protein biomarkers in human fluids
using site-specific antibody immobilization strategies. Sensors
14(2):2239–2258. doi:10.3390/s140202239
15. Byun JY, Shin YB, Li T, Park JH, Kim DM, Choi DH, Kim MG
(2013) The use of an engineered single chain variable fragment in a
localized surface plasmon resonance method for analysis of the C-
reactive protein. Chem Commun 49(82):9497–9499. doi:10.1039/
c3cc45046e
16. Bonroy K, Frederix F, Reekmans G, Dewolf E, De Palma R,
Borghs G, Declerck P, Goddeeris B (2006) Comparison of random
and oriented immobilisation of antibody fragments on mixed self-
assembled monolayers. J Immunol Methods 312(1–2):167–181.
doi:10.1016/j.jim.2006.03.007
17. Chen HX, Huang JY, Lee J, Hwang S, Koh K (2010) Surface
plasmon resonance spectroscopic characterization of antibody ori-
entation and activity on the calixarenemonolayer. Sens Actuators B
147(2):548–553. doi:10.1016/j.snb.2010.03.033
18. Lu B, Xie JM, Lu CL, Wu CG, Wei Y (1995) Oriented immobili-
zation of Fab' fragments on silica surfaces. Anal Chem 67(1):83–
87. doi:10.1021/ac00097a014
19. Shen ZH, Yan HP, Zhang Y, Mernaugh RL, Zeng XQ (2008)
Engineering peptide linkers for scFv immunosensors. Anal Chem
80(6):1910–1917. doi:10.1021/ac7018624
20. Torrance L, Ziegler A, Pittman H, Paterson M, Toth R, Eggleston I
(2006) Oriented immobilisation of engineered single-chain antibod-
ies to develop biosensors for virus detection. J Virol Methods
134(1–2):164–170. doi:10.1016/j.jviromet.2005.12.012
21. Trilling AK, Beekwilder J, Zuilhof H (2013) Antibody orientation
on biosensor surfaces: a minireview. Analyst 138(6):1619–1627.
doi:10.1039/c2an36787d
22. Vareiro MLM, Liu J, Knoll W, Zak K, Williams D, Jenkins ATA
(2005) Surface plasmon fluorescence measurements of human cho-
rionic gonadotrophin: role of antibody orientation in obtaining
1654 Plasmonics (2015) 10:1649–1655
enhanced sensitivity and limit of detection. Anal Chem 77(8):
2426–2431. doi:10.1021/ac0482460
23. Trilling AK, Hesselink T, van Houwelingen A, Cordewener JHG,
Jongsma MA, Schoffelen S, van Hest JCM, Zuilhof H, Beekwilder
J (2014) Orientation of llama antibodies strongly increases sensitiv-
ity of biosensors. Biosens Bioelectron 60:130–136. doi:10.1016/j.
bios.2014.04.017
24. Walper SA, Lee PAB, Goldman ER, Anderson GP (2013)
Comparison of single domain antibody immobilization strategies
evaluated by surface plasmon resonance. J Immunol Methods
388(1–2):68–77. doi:10.1016/j.jim.2012.11.014
25. Walper SA, Lee PAB, Anderson GP, Goldman ER (2013) Selection
and characterization of single domain antibodies specific for
Bacillus anthracis spore proteins. Antibodies 2:152–167
26. Turner KB, Zabetakis D, Legler P, Goldman ER, Anderson GP
(2014) Isolation and epitopemapping of staphylococcal enterotoxin
B single-domain antibodies. Sensors 14(6):10846–10863.
doi:10.3390/s140610846
27. Anderson G, Liu J, Hale M, Bernstein R, Moore M, Swain M,
Goldman E (2008) Development of antiricin single domain anti-
bodies toward detection and therapeutic reagents. Anal Chem
80(24):9604–9611. doi:10.1021/ac8019398
28. Anderson G, Bernstein R, Swain M, Zabetakis D, Goldman E
(2010) Binding kinetics of antiricin single domain antibodies and
improved detection using a B chain specific binder. Anal Chem
82(17):7202–7207. doi:10.1021/ac100961x
29. Raphael MP, Christodoulides JA, Mulvaney SP, Miller MM, Long
JP, Byers JM (2012) A new methodology for quantitative LSPR
biosensing and imaging. Anal Chem 84(3):1367–1373. doi:
10.1021/ac2023266
30. Goldman ER, Brozozog-Lee PA, Zabetakis D, Turner KB, Walper
SA, Liu JL, Anderson GP (2014) Negative tail fusions can improve
ruggedness of single domain antibodies. Protein Expr Purif 95:226–
232. doi:10.1016/j.pep.2014.01.003
31. Oshea EK, Lumb KJ, Kim PS (1993) Peptide velcro—design of a
heterodimeric coiled-coil. Curr Biol 3(10):658–667. doi:10.1016/
0960-9822(93)90063-t
32. Goldman ER, Anderson GP, Brozozog-Lee PA, Zabetakis D (2013)
SdAb heterodimer formation using leucine zippers. In: Conference
on Sensing Technologies for Global Health, Military Medicine, and
Environmental Monitoring III, Baltimore, MD, Apr 29-May 01
2013. Proceedings of SPIE 8723. Spie-Int Soc Optical
Engineering, BELLINGHAM. doi:10.1117/12.2016145
33. Liu JL, Zabetakis D, Walper SA, Goldman ER, Anderson GP
(2014) Bioconjugates of rhizavidin with single domain antibodies
as bifunctional immunoreagents. J Immunol Methods 411:37–42.
doi:10.1016/j.jim.2014.06.004
34. Raphael MP, Christodoulides JA, Delehanty JB, Long JP, Pehrsson
PE, Byers JM (2013) Quantitative LSPR imaging for biosensing
with single nanostructure resolution. Biophys J 104(1):30–36. doi:
10.1016/j.bpj.2012.11.3821
35. Stenberg E, Persson B, Roos H, Urbaniczky C (1991)
Quantitative-determination of surface concentration of pro-
tein with surface-plasmon resonance using radiolableled pro-
teins. J Colloid Interface Sci 143(2):513–526. doi:10.1016/
0021-9797(91)90284-f
Plasmonics (2015) 10:1649–1655 1655
